Hutch News
Results per Page:
For the best stem cells, mimic their native niche
By the Delaney lab, Clinical Research Division
Study aims to cure blood cancers with transplants that could block HIV, too
10 HIV-positive cancer patients to receive donated cord blood with rare resistance gene
Data drives life sciences boom in Seattle
Hutch leaders, entrepreneurs stress importance of partnerships at Life Science Innovation Northwest conference
Scientists-turned-entrepreneurs share lessons learned launching startups
From venture capital to office space to acquisitions, academics starting companies face a steep learning curve — but there’s help to be found
Drs. Beverly Torok-Storb, Colleen Delaney receive Seattle AWIS Awards
Honored for excellence in science education, advancement and STEM leadership
Good News: Kleberg Foundation grant to support clinical trial for leukemia patients
Celebrating faculty and staff achievements
Good News: GeekWire Award Finalists include Bezos Family Immunotherapy Clinic and Nohla Therapeutics, among others
Celebrating faculty and staff achievements
Bezos family gives $35 million to Fred Hutch
‘What we are really giving is the gift of time’; funds will be invested in more world-class faculty to speed cures for cancer patients
Bezos family gives $35 million to Fred Hutch
Transformative investment will be used to hire more world-class researchers to launch innovative approaches to curing cancer, said Fred Hutch President and Director Gilliland
Fred Hutch holiday gala raises more than $13 million for pediatric cancer research
Fred Hutch Holiday Gala brings in more than $13 million to grow pediatric cancer research and develop needed therapies for children
The rooms that remain: Coping with grief after a child dies
Some parents grieve children lost to cancer by preserving precious spaces – their kids’ bedrooms
Inaugural 'Oncology Summit' addresses academic-industry partnerships
Fred Hutch, Merck co-host inaugural ‘Oncology Summit’ to capture non-profit and for-profit outlooks on cancer care
Umbilical cord blood transplant linked to lower relapse in high-risk leukemia patients
Study compares ‘alternative’ donor source vs. traditional transplantation of blood stem cells from an adult, unrelated donor
DeFeatHIV receives second five-year grant from NIH to research gene and cell therapies
The funding allows Fred Hutch’s HIV cure program to both extend and expand
First test of 'off-the-shelf' cord blood cell product outside the transplantation setting
Celebrating faculty and staff achievements
Drs. Colleen Delaney, Harlan Robins named 2016 Leaders in Health Care
Celebrating faculty and staff achievements
'Something everyone can get': New spinoff to commercialize cord blood stem cell therapies
New Fred Hutch spinoff to commercialize cord blood stem cell therapies based on work by Drs. Colleen Delaney, Irwin Bernstein
'A chance to hope’: Leukemia survivor, family reunite with favorite doctor
Ex-patient’s wife recalls how her sacred mission to save her husband led her to Fred Hutch
Remembering Fred Hutch's Dr. Harold Weintraub 20 years later
20 years after Dr. Harold Weintraub’s death, his life — and his research — are still making a difference
Cord blood: 'The biggest blessing ever'
Cord blood: a lifesaving option for those in need of a transplant but cannot find a matched donor